A new study has revealed that people with persistently higher levels of omega-6 as compared to omega-3 fatty acids in their blood, as well as consistently low DHA levels, had more psychotic experiences at age 24.
Adequate intake of omega-3 fatty acids is recommended for general health, and the balance of omega-6 to omega-3s is thought to be important for various physical and mental health benefits.
(Source: Pixabay)
Bristol/UK – Led by Queen’s University Belfast, the longitudinal study, using data from the University of Bristol's Children of the 90s, examined how blood levels of omega-6 and omega-3 fatty acids, as well as a specific omega-3 fatty acid called docosahexaenoic acid (DHA), changed over time. Working in collaboration with researchers from the University of Cambridge and RCSI University of Medicine and Health Sciences, the aim was to identify if, and how, these variations were related to the development of symptoms of psychosis in young adults aged 24.
Researchers tracked the participants, who are part of the Avon Longitudinal Study of Parents and Children (ALSPAC), also known as ‘Children of the 90s’, from childhood into adulthood. The fatty acid levels were measured in the blood tests collected from the participants throughout their lives, at the specific ages of 7, 15, 17 and 24 years old.
The findings reveal that those with persistently higher levels of omega-6 compared to omega-3 fatty acids in their blood, as well as consistently low DHA levels, had more psychotic experiences at age 24 compared to people whose levels remained average over this time period. Psychotic experiences include thoughts of paranoia or hearing sounds others cannot.
In addition, these participants also showed greater negative symptoms of psychosis. Negative symptoms include experiencing a loss of interest in activities, flattening of emotions and social withdrawal.
Adequate intake of omega-3 fatty acids is recommended for general health, and the balance of omega-6 to omega-3s is thought to be important for various physical and mental health benefits.
Foods high in omega-3 include certain fish and seafood, some vegetable oils, nuts, and high fat plant foods such as chia seeds, flaxseeds, brussels sprouts and more. Omega-6 fatty acids can be found in sunflower, safflower, soy, sesame, and corn oils.
Commenting on the significance of the findings, Dr. David Mongan, Academic Clinical Lecturer at Queen’s University, said: “This inaugural study is important because the results suggest that optimizing fatty acid status during crucial stages of development, whether through diet or supplementation, warrants further investigation in relation to reducing psychotic symptoms in early adulthood.”
Dr. Ben Perry, Department of Psychiatry, University of Cambridge added: “We’ve found an interesting link between higher ratios of omega-6 to omega-3 fatty acids during childhood and adolescence and an increase in experiences of psychosis in adulthood. We don’t yet know why this should be case, but nor do we believe people should be concerned by these findings. Omega-6 fatty acids as part of a balanced diet are important nutrients and we would not recommend people cut them out of their diets. We hope future research will explore this possible link between diet and mental health in more detail.”
In addition, Professor David Cotter, Professor of Molecular Psychiatry at RCSI said: "Building on our previous research, these findings reinforce our understanding of the important relationship between fatty acids and later mental health, particularly in how an imbalance between omega-6 and omega-3 can increase the risk of later psychotic experiences.”
Commenting on the findings through the use of ALSPAC data, Principal Investigator, Professor Nic Timpson, added: “The health data that has been collected at Children of the 90s enables life-changing research and here is an example of a fascinating study with the potential to have an impact on future research which could help guide dietary advice.”
Paper: ‘Longitudinal trajectories of plasma polyunsaturated fatty acids and associations with psychosis spectrum outcomes in early adulthood’ by David Mongan et al. in Biological Psychiatry.
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.